Organization · Venture Capital
Nordic Science Capital
Nordic Science Capital is a biotech incubation organization based in Solna, Sweden, focusing on inception-stage ideas from leading universities. It partners with scientists to co-found companies and file patents.
Overview
What Nordic Science Capital does
What Nordic Science Capital is
Nordic Science Capital is a biotech incubation organization based in Solna, Sweden, focusing on inception-stage ideas from leading universities. It partners with scientists to co-found companies and file patents.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- March 31, 2026
Official channels
Find Nordic Science Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Nordic Science Capital as a funder
Investment thesis
Nordic Science Capital invests in inception-stage biotech ideas emerging from leading Swedish universities, focusing on scientists who hold patents and actively collaborating in company formation.
Focus narrative
Nordic Science Capital specializes in the life sciences sector, particularly targeting inception-stage biotech ideas. The organization emphasizes a hands-on approach, working directly with scientists and researchers to develop their innovations into successful companies.
Value beyond capital
Nordic Science Capital adds value by actively co-founding companies alongside scientist-founders, assisting in patent filings, and providing executive support. This hands-on involvement helps accelerate the development of innovative biotech solutions.
Focus and fit
- Stages
- Pre-seed · Friends and Family
- Regions
- Europe
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 3
Portfolio context
Bioinferix: Develops personalized oncology solutions for real-time cancer diagnosis and treatment using a single photonic procedure. Moligo Technologies: Specializes in ultra-long, ultra-pure, customizable ssDNA, utilizing an enzymatic approach that significantly enhances the length and accuracy of oligonucleotides. AnPro Labs: Focuses on protein engineering for biopharma and industrial processes, offering improved processes that lead to faster market entry, increased stability, and higher yields.
Common questions
What to know about Nordic Science Capital
Upseed classifies Nordic Science Capital under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 31, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.